Core Laboratories Inc. (CLB)
Energy · NYQ
Price as at 1 Oct 2026, 10:47 UTC. Quotes are delayed.
Fundamentals
Valuation and ratings
Core Laboratories Inc. trades at $9.70, which is 40% above the $5.84 our fair value estimate puts on the business. On that measure it screens as expensive, which is not the same as saying it will fall.
Our moat model scores it 26 out of 100, which is little in the way of a moat. A moat is a structural reason competitors cannot take the profits away, and it matters more to a long holding period than any single quarter's numbers do.
It changes hands at 19.7 times earnings. Be careful reading that in isolation: for a cyclical business a low P/E arrives at the top of the cycle, when profits are peaking and about to fall, which is exactly when the shares look cheapest and are not.
CLB dividend history
Dividends per share by year
| Year | Total per share | Payments |
|---|---|---|
| 2026 (year to date) | $0.030 | 3 |
| 2025 | $0.040 | 4 |
| 2024 | $0.040 | 4 |
| 2023 | $0.040 | 4 |
| 2022 | $0.040 | 4 |
| 2021 | $0.040 | 4 |
| 2020 | $0.280 | 4 |
| 2019 | $2.20 | 4 |
| 2018 | $1.65 | 3 |
| 2017 | $2.20 | 4 |
| 2016 | $2.20 | 4 |
Split-adjusted amounts in the listing currency, grouped by the calendar year of the ex-dividend date, from the filed record. Growth and streak figures compare complete years only.
CLB earnings and analyst estimates
Recommendation mix, 3 published ratings
Estimates are the published analyst consensus and move often. An earnings date is scheduled, not certain, and a share tends to reprice most violently on the day itself.
About Core Laboratories Inc.
Core Laboratories Inc. provides reservoir description and production enhancement services and products to the oil and gas industry in the United States, and internationally. It operates through Reservoir Description and Production Enhancement segments. The Reservoir Description segment includes the characterization of petroleum reservoir rock and reservoir fluid samples to enhance production and improve recovery of crude oil and natural gas from its clients' reservoirs. It offers laboratory-based analytical and field services to characterize properties of crude oil and oil delivered products; and proprietary and joint industry studies, as well as services that support carbon capture, utilization and storage, geothermal projects, and the evaluation and appraisal of mining activities. The Production Enhancement segment provides services and products relating to reservoir well completions, perforations, stimulations, production, and well abandonment. It offers integrated diagnostic services to evaluate and monitor the effectiveness of well completions and to develop solutions to improve the effectiveness of enhanced oil recovery projects. The company markets and sells its products through a combination of sales representatives, technical seminars, trade shows, and print advertising, as well as through distributors. Core Laboratories Inc. was founded in 1936 and is based in Houston, Texas.
Company profile, industry and headcount are as reported by our data provider and can lag a company's own filings by a reporting period. The annual report is the authority.
CLB passes 2 of our 30 screens today
Each screen prints the exact criteria it used, and the circumstances in which it is wrong.
Super investor ownership
6 of the funds we track reported a position in their latest SEC 13F filing. Largest first:
- John Rogers, ARIEL INVESTMENTS, LLC$163.97M · 1.6% of book
- Ken Fisher, Fisher Asset Management, LLC$5.22M · 0.0% of book
- Ken Griffin, CITADEL ADVISORS LLC$4.33M · 0.0% of book
- D. E. Shaw, D. E. Shaw & Co., Inc.$2.89M · 0.0% of book
- Cliff Asness, AQR CAPITAL MANAGEMENT LLC$755.0K · 0.0% of book
A word of warning on reading these figures: a 13F reports the market value of a holding, so a fund that traded nothing at all still appears to have sold when the price fell. We found 102 companies where the standard reading gives the opposite answer. Only the share count is honest.
CLB peers
The largest companies in the same industry (Oil & Gas Equipment & Services), then in the same sector.
- BKR Baker Hughes Company
- FTI TechnipFMC plc
- TS Tenaris S.A.
- SEI Solaris Energy Infrastructure, Inc.
- OII Oceaneering International, Inc.
- WHD Cactus, Inc.
- FLOC Flowco Holdings Inc.
- NEXT NextDecade Corporation
Every energy company we cover is on the Energy hub.
Common questions
Is Core Laboratories Inc. (CLB) undervalued?
Against our fair value estimate of $5.84, CLB at $9.70 is 40% above fair value. That is one model's answer, not a recommendation. It is built from normalized earning power with growth capped deliberately low, which understates companies whose value is mostly future growth.
Which funds own CLB?
6 of the institutions we track reported a position in CLB in their most recent SEC 13F filing. A 13F is filed up to 45 days after quarter end, so it tells you what a fund held then, not what it holds now.
What is CLB's P/E ratio?
CLB trades at 19.7 times earnings. A low P/E is not automatically cheap: on a cyclical company it is usually a warning that earnings are at a peak.
Does Core Laboratories Inc. (CLB) pay a dividend?
Yes. Core Laboratories Inc. yields 0.33% at the current share price. It has paid $0.040 per share over the trailing twelve months. It has paid a dividend in each of the last 18 complete calendar years. A dividend is declared by the board and can be cut at any time; a yield is a fact about the current price, not a promise.
Where does SteadyShares get its CLB data?
Fundamentals for CLB come from company filings and exchange data, as listed on NYQ; institutional ownership comes from SEC 13F filings. The share price shown was last refreshed on 1 Oct 2026, 10:47 UTC and is delayed. Our data quality score for this company is 96/100, which is the share of the inputs behind our scores that were actually available rather than assumed. Metrics we do not hold are left out of the page rather than estimated.
The full research page for CLB, with financial statements, ownership detail, peer comparison and alerts, is free inside the app.
Data from company filings, exchange quotes and SEC EDGAR 13F disclosures. Quotes are delayed. Metrics we do not have are left out rather than estimated. Educational information, not financial advice.